Bioorganic and Medicinal Chemistry p. 2045 - 2055 (2013)
Update date:2022-08-02
Topics:
Kusakabe, Ken-Ichi
Tada, Yukio
Iso, Yasuyoshi
Sakagami, Masahiro
Morioka, Yasuhide
Chomei, Nobuo
Shinonome, Satomi
Kawamoto, Keiko
Takenaka, Hideyuki
Yasui, Kiyoshi
Hamana, Hiroshi
Hanasaki, Kohji
Selective CB2 agonists have the potential for treating pain without central CB1-mediated adverse effects. Screening efforts identified 1,2-dihydro-3- isoquinolone 1; however, this compound has the drawbacks of being difficult to synthesize with two asymme
View MoreShanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Zhejiang Kaili Industrial Co., Ltd
Contact:+86-571-85241926
Address:lantian business center,No.18 Moganshan Road
Wuhan Chemwish Technology Co., Ltd
website:http://www.chemwish.com/
Contact:+86-27-67849912
Address:Room 1311, Unit 2, Block1, Innovation Road East Lake High-tech Development Zone Wuhan, Hubei,P.R. China
Xi'an caijing Opto-Electrical Science & Technology Co., LTD
Contact:+86-29-88294447
Address:NO.168 Zhangba Rd. East, Xi'an, P.R.China
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Doi:10.1016/S0040-4039(00)84590-6
(1986)Doi:10.1002/hlca.19980810543
(1998)Doi:10.1007/BF00909912
(1970)Doi:10.1039/b001988g
(2000)Doi:10.1021/ja00710a050
(1970)Doi:10.1016/S0040-4039(01)90444-7
(1981)